Unitree, one of the world’s largest producers of quadruped and humanoid robots, has seen its shares plunge roughly 45% from their post-IPO peak after a more than fivefold surge on debut, reigniting debates over valuation excesses in China’s tech listings.
The company’s shares, which surged 460% on their debut last Wednesday, have since retreated sharply, wiping out $30 billion of its peak $66 billion valuation. The decline followed three consecutive days of losses, though trading stabilized on Tuesday. The stock’s trajectory mirrors broader concerns about speculative fervor in China’s initial public offerings, particularly in sectors tied to Beijing’s self-sufficiency drive and strategic industries.
Unitree’s adjusted net profit fell 53% to 40 million yuan ($5.95 million) in the first three months of 2026, according to its prospectus. Analysts note that while the company’s robots—capable of running, dancing, and performing martial arts—have garnered attention, commercial applications remain limited. Comparisons have been drawn to the early stages of China’s electric vehicle industry, where early losses were tolerated amid long-term growth potential.
The episode has drawn criticism from market participants over perceived flaws in China’s IPO system. Analysts cite restricted short-selling activity, regulatory guidance on pricing that limits underwriters’ flexibility, and a lack of immediate pushback against overpriced listings. Dong Baozhen, chairman of Beijing-based asset manager Lingtong Shengtai, described the surge as driven by a "technology revolution narrative" and warned that "all bubbles are doomed to burst." He added that either IPO pricing or debut performance must be incorrect, with exuberant market mood breeding speculative excess.
Abraham Zhang, chairman of venture capital firm China Europe Capital, argued that Unitree’s debut gains were not driven by fundamentals but by opportunistic trading. He noted that IPO subscribers exited profitably, leaving retail investors exposed to losses. "The capital drama seen in the Unitree listing is not the first in China, and will not be the last," Zhang said. Other fund managers echoed concerns. Gao Xingkun of China Southern Asset Management Co. highlighted the gap between heavy R&D spending and the absence of commercial orders in robotics, while Yuan Yuwei of Trinity Synergy Investments criticized the concentration of wealth at the expense of retail investors.
The episode follows a 466% surge in shares of DRAM chipmaker CXMT during its Shanghai debut last month, underscoring broader investor appetite for China’s strategic sectors. However, the number of IPOs in Shanghai remains subdued, with only 21 listings in the first seven months of the year compared to 104 in Hong Kong, reflecting cautious market sentiment amid regulatory and valuation concerns.
